On Sunday, April 20th 2025, starting 8:30am GMT, there will be maintenance work that will involve the website being unavailable during parts of the day. We apologize for any inconvenience this may cause and appreciate your understanding.
We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Talk outline
- Consumer branding is another world
- What do the following brands have in common?
- US brand leaders in 1925 and 1985
- FMCG Longevity of brands
- A little known table
- Product brands with staying power
- But this is how we think about it
- Pharma brands vs. FMCG brands - brand building
- Differences in attitude to brand building
- Why the difference?
- The product attribute trap
- Brand theory can be confusing
- Few pharma people really understand the basics
- Brand identity vs. brand image
- Fewer understand the latest thinking
- The neuro-cultural view of brands
- Brand function hierarchy
- Operating within changing markets
- Put simply
- Brand equity value creation in pharma
- Future of branding in pharmaceutical industry (1)
- Brand architecture
- How does this relate to pharma?
- Pharmaceutical portfolio's
- Kapferer theory
- Kapferer brand architecture theory
- Pharma equivalents?
- Pharmaceutical brand strategy hierarchy
- One additional pharma brand extension strategy
- Aaker brand driver roles
- Aaker brand architecture
- Aaker corporate brand strategy examples
- What can we learn from the consumer world?
- What can we learn?
- Future of branding in pharmaceutical industry (2)
- Brand management needs to add value
- The pharmaceutical industry's value curve
- How does consumer brand management advance?
- Brand management evolving paradigm
- What do we need to do?
- Pharmaceutical brand logic
- What we need to do - pharmaceutical brand logic
- Thank you
Topics Covered
- How has consumer branding developed and what are the differences between it and pharmaceutical branding
- Established consumer brand architecture and how to apply it to pharmaceuticals
- Kapferer and Aaker theory and how it can be applied
- The future for branding within pharmaceuticals
Talk Citation
Moss, G.D. (2009, January 28). The future of branding within the pharmaceutical industry [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved April 15, 2025, from https://doi.org/10.69645/UJNH8098.Export Citation (RIS)
Publication History
- Published on January 28, 2009
Financial Disclosures
- Mr. Giles D. Moss has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.